Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
Oncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient activation and engagement. To accomplish this goal, pharmacists can target health system-related, provider-related, and patient-related facto...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/9/3/130 |
_version_ | 1797517543578009600 |
---|---|
author | Shannon Palmer Ashley Chen Taylor Dennison Cameron Czech Jessica Auten Kaitlyn Buhlinger Benyam Muluneh |
author_facet | Shannon Palmer Ashley Chen Taylor Dennison Cameron Czech Jessica Auten Kaitlyn Buhlinger Benyam Muluneh |
author_sort | Shannon Palmer |
collection | DOAJ |
description | Oncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient activation and engagement. To accomplish this goal, pharmacists can target health system-related, provider-related, and patient-related factors to enhance patient-centered care and drive behavioral health changes. Interventions that pharmacists must tackle include educating team members and patients on the medication acquisition process, communicating urgency of treatment, optimizing workflows, facilitating guideline recommendations, preventing, and managing treatment toxicities, and promoting patient self-advocacy through education and shared decision-making. As crucial members of the healthcare team, oncology pharmacists can simplify highly complex treatment regimens to facilitate and optimize patients’ ownership of their care. This narrative review will focus on the example of venetoclax treatment in acute myeloid leukemia to demonstrate the impact that pharmacists provide that leads to behavioral change of patients and clinicians. |
first_indexed | 2024-03-10T07:18:00Z |
format | Article |
id | doaj.art-125320b66771429f9e2468e824a4d0dd |
institution | Directory Open Access Journal |
issn | 2226-4787 |
language | English |
last_indexed | 2024-03-10T07:18:00Z |
publishDate | 2021-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmacy |
spelling | doaj.art-125320b66771429f9e2468e824a4d0dd2023-11-22T14:49:15ZengMDPI AGPharmacy2226-47872021-07-019313010.3390/pharmacy9030130Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral OncolyticsShannon Palmer0Ashley Chen1Taylor Dennison2Cameron Czech3Jessica Auten4Kaitlyn Buhlinger5Benyam Muluneh6Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USAUNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27514, USAOncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient activation and engagement. To accomplish this goal, pharmacists can target health system-related, provider-related, and patient-related factors to enhance patient-centered care and drive behavioral health changes. Interventions that pharmacists must tackle include educating team members and patients on the medication acquisition process, communicating urgency of treatment, optimizing workflows, facilitating guideline recommendations, preventing, and managing treatment toxicities, and promoting patient self-advocacy through education and shared decision-making. As crucial members of the healthcare team, oncology pharmacists can simplify highly complex treatment regimens to facilitate and optimize patients’ ownership of their care. This narrative review will focus on the example of venetoclax treatment in acute myeloid leukemia to demonstrate the impact that pharmacists provide that leads to behavioral change of patients and clinicians.https://www.mdpi.com/2226-4787/9/3/130patient activationpatient engagementbehavioral health changeself-administered therapyoral oncolytic |
spellingShingle | Shannon Palmer Ashley Chen Taylor Dennison Cameron Czech Jessica Auten Kaitlyn Buhlinger Benyam Muluneh Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics Pharmacy patient activation patient engagement behavioral health change self-administered therapy oral oncolytic |
title | Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics |
title_full | Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics |
title_fullStr | Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics |
title_full_unstemmed | Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics |
title_short | Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics |
title_sort | impact of oncology pharmacists on the knowledge attitude and practices of clinicians to enhance patient engagement of self administered oral oncolytics |
topic | patient activation patient engagement behavioral health change self-administered therapy oral oncolytic |
url | https://www.mdpi.com/2226-4787/9/3/130 |
work_keys_str_mv | AT shannonpalmer impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics AT ashleychen impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics AT taylordennison impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics AT cameronczech impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics AT jessicaauten impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics AT kaitlynbuhlinger impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics AT benyammuluneh impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics |